v3.26.1
Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of assets and liabilities that are measured at fair value on a recurring basis
                     
Description   Level     March 31,
2026
    December 31,
2025
 
          (Unaudited)        
Assets:                      
Marketable securities held in Trust Account   1     $ 57,929,106     $ 57,425,636  
Schedule of ordinary shares subject to redemption
       
Gross proceeds   $ 55,950,000  
Less:        
Proceeds allocated to public rights     (6,461,922 )
Offering costs allocated to redeemable shares     (1,156,981 )
Plus:        
Accretion of carrying value to redemption value     4,991,952  
Ordinary shares subject to possible redemption as of December 31, 2025   $ 53,323,049  
Plus:      
Accretion of carrying value to redemption value     2,033,969  
Ordinary shares subject to possible redemption as of March 31, 2026 (Unaudited)   $ 55,357,018  
Schedule of unaudited condensed statement of operations and comprehensive income
               
    For the
Three Months Ended
March 31,
 
    2026     2025  
    (Unaudited)     (Unaudited)  
Net income (loss)   $ 371,705     $ (75,157 )
Less: Accretion of redeemable ordinary shares to redemption value     2,033,969       -  
Net loss including accretion of redeemable ordinary shares to redemption value     (1,662,264 )     (75,157 )

Earnings (loss) per share presented on the unaudited condensed consolidated statement of operations and comprehensive income (loss) is based on the following:

 

                               
    For the Three Months Ended March 31,  
    2026     2025  
    Redeemable
Ordinary Share
    Non-Redeemable
Ordinary Share
    Redeemable
Ordinary Share
    Non-Redeemable
Ordinary Share
 
    (Unaudited)     (Unaudited)  
Numerators:                                
Allocation of net loss   $ (1,273,399 )   $ (388,865 )   $ -   $ (75,157 )
Accretion of redeemable ordinary shares to redemption value     2,033,969       -       -       -  
Allocation of net income (loss)   $ 760,570     $ (388,865 )   $ -     $ (75,157 )
                                 
Denominators:                                
Weighted-average ordinary shares outstanding     5,595,000       1,708,575       -       1,250,000  
Basic and diluted earnings (loss) per share   $ 0.14     $ (0.23 )   $ -     $ (0.06 )
Schedule of unaudited condensed statement of operations and comprehensive income
                               
    For the Three Months Ended March 31,  
    2026     2025  
    Redeemable
Ordinary Share
    Non-Redeemable
Ordinary Share
    Redeemable
Ordinary Share
    Non-Redeemable
Ordinary Share
 
    (Unaudited)     (Unaudited)  
Numerators:                                
Allocation of net loss   $ (1,273,399 )   $ (388,865 )   $ -   $ (75,157 )
Accretion of redeemable ordinary shares to redemption value     2,033,969       -       -       -  
Allocation of net income (loss)   $ 760,570     $ (388,865 )   $ -     $ (75,157 )
                                 
Denominators:                                
Weighted-average ordinary shares outstanding     5,595,000       1,708,575       -       1,250,000  
Basic and diluted earnings (loss) per share   $ 0.14     $ (0.23 )   $ -     $ (0.06 )